BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline
NetBox Labs Adds Dozens of Enterprise Customers, Including Seven Fortune 500 Organizations, and Celebrates Massive NetBox Innovation and Community Growth In First Year
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event